# EDGAR Filing Document

**Accession Number:** 0001389182
**File Stem:** 0001104659-25-114106
**Filing Date:** 2025-11
**Character Count:** 14233
**Document Hash:** ce4a7501a59892654786b34c518aae98
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-114106.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001104659-25-114106

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Danaos Corp
- **CENTRAL INDEX KEY:** 0001369241
- **STANDARD INDUSTRIAL CLASSIFICATION:** DEEP SEA FOREIGN TRANSPORTATION OF FREIGHT [4412]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 000000000
- **STATE OF INCORPORATION:** 1T
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-82502
- **FILM NUMBER:** 251499533

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 14 AKTI KONDYLI
- **STREET 2:** 185 45 PIRAEUS
- **CITY:** ATHENS
- **PROVINCE COUNTRY:** J3
- **BUSINESS PHONE:** 011302104496480

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 14 AKTI KONDYLI
- **STREET 2:** 185 45 PIRAEUS
- **CITY:** ATHENS
- **PROVINCE COUNTRY:** J3
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Danaos Investment LTD as Trustee of the 883 Trust
- **CENTRAL INDEX KEY:** 0001389182

**ORGANIZATION NAME:**
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O 14 AKTI KONDYLI
- **CITY:** 185 45 PIRAEUS
- **PROVINCE COUNTRY:** J3
- **BUSINESS PHONE:** 30 210 419 6480

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O 14 AKTI KONDYLI
- **CITY:** 185 45 PIRAEUS
- **PROVINCE COUNTRY:** J3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Danaos Investments LTD as Trustee of the 883 Trust
- **DATE OF NAME CHANGE:** 20070207

## Exhibit 99.1

**Exhibit 1**

JOINT FILING AGREEMENT

Dated: November 19, 2025

The undersigned hereby agree that Amendment No. 9 dated November 19, 2025 (the "<u>Amendment No. 9</u>") to the Statement on Schedule 13D with respect to the Common Stock, $0.01 par value, of Danaos Corporation dated August 16, 2010 (the "<u>Statement on Schedule 13D</u>") is, and any further amendments to the Statement on Schedule 13D executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Joint Filing Agreement shall be included as an Exhibit to the Amendment No. 9. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

*[Signature Page Follows]*

IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement as of the date first above written.

---

| | | |
|:---|:---|:---|
| DANAOS INVESTMENT LIMITED AS TRUSTEE OF THE 883 TRUST | DANAOS INVESTMENT LIMITED AS TRUSTEE OF THE 883 TRUST | DANAOS INVESTMENT LIMITED AS TRUSTEE OF THE 883 TRUST |
| By: | /s/ Iraklis Prokopakis | /s/ Iraklis Prokopakis |
|  | Name: | Iraklis Prokopakis |
|  | Title: | Director |
| By: | /s/ Evangelos Chatzis | /s/ Evangelos Chatzis |
|  | Name: | Evangelos Chatzis |
|  | Title: | Director |
| JOHN COUSTAS | JOHN COUSTAS | JOHN COUSTAS |
| /s/ John Coustas | /s/ John Coustas | /s/ John Coustas |

---

[Signature Page to Joint Filing Agreement]

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 9)**

**DANAOS CORPORATION**

*(Name of Issuer)*

**Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**Y1968P121**

*(CUSIP Number)*

**Finnbarr D. Murphy**<br>Goodwin Procter LLP<br>620 Eighth Avenue<br>New York NY 10012<br>(212) 459-7257

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/14/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **Y1968P121** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Danaos Investment Limited as Trustee of the 883 Trust** | Name of reporting person<br>**Danaos Investment Limited as Trustee of the 883 Trust** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**Q2** | Citizenship or place of organization<br>**Q2** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**9538502.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**9538502.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**9538502.00** | Aggregate amount beneficially owned by each reporting person<br>**9538502.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**51.8%** | Percent of class represented by amount in Row (11)<br>**51.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **Y1968P121** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**John Coustas** | Name of reporting person<br>**John Coustas** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**J3** | Citizenship or place of organization<br>**J3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**9538502.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**9538502.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**9538502.00** | Aggregate amount beneficially owned by each reporting person<br>**9538502.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**51.8%** | Percent of class represented by amount in Row (11)<br>**51.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) These shares of Common Stock are held by Danaos Investment Limited as Trustee of the 883 Trust ("DIL"), which has sole voting and dispositive control over these shares of Common Stock. The beneficiaries of the 883 Trust are Dr. Coustas and members of his immediate family. The board of directors of DIL consists of five members, none of whom is a beneficiary of the 883 Trust or member of the Coustas family, and has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as Trustee of the 883 Trust and, accordingly, he may be deemed to beneficially own these 9,538,502 shares of Common Stock. This does not necessarily imply economic ownership of the securities.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
DANAOS CORPORATION

**(c) Address of Issuer's Principal Executive Offices:**
c/o Danaos Shipping Co. Ltd., 14 Akti Kondyli, Piraeus, J3, 185 45

This Amendment No. 9 to the Statement on Schedule 13D originally filed on August 16, 2010, as amended by Amendment No. 1 on August 14, 2018, Amendment No. 2 on December 2, 2019, Amendment No. 3 on September 14, 2021, Amendment No. 4 on April 15, 2022, Amendment No. 5 on November 15, 2023 and Amendment No. 6 on November 13, 2024, Amendment No. 7 on January 16, 2025 and Amendment No. 8 on April 9, 2025 (the "Statement"), relates to the common stock, par value $0.01 per share ("Common Stock"), of Danaos Corporation, a Marshall Islands corporation (the "Company"), and is being filed by (i) Danaos Investment Limited, a company organized under the laws of New Zealand, as Trustee of the 883 Trust, a trust established under the laws of the Cayman Islands ("DIL"), and (ii) Dr. John Coustas ("Dr. Coustas" and, together with DIL as Trustee of the 883 Trust, the "Reporting Persons"). Information given in response to each item below shall be deemed incorporated by reference in all other items below. Unless indicated otherwise, all items left blank remain unchanged, and any items which are amended below are deemed to amend and update the existing items in the Schedule 13D.

**Item 4. Purpose of Transaction**

Item 4 of the Statement is hereby amended by adding the following paragraphs to the end of Item 4:

This Amendment No. 9 updates the number of shares of Common Stock beneficially owned by the Reporting Persons to reflect that on November 14, 2025, 100,000 shares of Common Stock were granted to Dr. Coustas as a compensatory equity award and are held by DIL and 100,000 shares were acquired by DIL pursuant to the Amended and Restated Management Agreement. This Amendment No. 9 also updates the percentage of outstanding Common Stock of the Company beneficially owned by the Reporting Persons, including to reflect repurchases under the Company's common stock repurchase program.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Statement is hereby amended and restated to read as follows: DIL, as Trustee of the 883 Trust, is the owner of 9,538,502 shares of Common Stock, which represents 51.8% of the outstanding shares of Common Stock. DIL, as Trustee of the 883 Trust, has sole voting and dispositive control over these shares of Common Stock. The beneficiaries of the 883 Trust are Dr. Coustas and members of his immediate family. The board of directors of DIL consists of five members, none of whom is a beneficiary of the 883 Trust or member of the Coustas family, or has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as Trustee of the 883 Trust and, accordingly, he may be deemed to beneficially own these 9,538,502 shares of Common Stock. This does not necessarily imply economic ownership of the securities.

Iraklis Prokopakis beneficially owns 200,270 shares of Common Stock, or approximately 1.1% of the outstanding shares of Common Stock. He has sole voting and dispositive power with respect to such shares.

Evangelos Chatzis beneficially owns 50,000 shares of Common Stock, or less than 1.0% of the outstanding shares of Common Stock. He has sole voting and dispositive power with respect to such shares.

Dimitrios Charkoplias beneficially owns 120 shares of Common Stock, or less than 1.0% of the outstanding shares of Common Stock. He has sole voting and dispositive power with respect to such shares.

(a) See Items 11 and 13 on the cover pages to this Schedule 13D/A for the aggregate number and percentage of the class of securities identified pursuant to Item 1 owned by each Reporting Person.

**(b)**
Number of shares as to which each Reporting Person has: i. Sole power to vote or to direct the vote: See Item 7 on cover pages to this Amendment. ii. Shared power to vote or to direct the vote: See Item 8 on cover pages to this Amendment. iii. Sole power to dispose or direct the disposition: See Item 9 on cover pages to this Amendment. iv. Shared power to dispose or direct the disposition: See Item 10 on cover pages to this Amendment.

**(c)**
Other than as set forth in response to Item 5, no transactions in the Company's Common Stock by the Reporting Persons and the Shareholder Directors were effected in the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Statement is hereby amended by adding the following paragraph. See the responses to Item 3, Item 4 and Item 5, which are incorporated by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Danaos Investment Limited as Trustee of the 883 Trust

**Signature:** /s/ Iraklis Prokopakis

**Name/Title:** IRAKLIS PROKOPAKIS / Director

**Date:** 11/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** John Coustas

**Signature:** /s/ John Coustas

**Name/Title:** John Coustas

**Date:** 11/19/2025